In contrast, our approach investigates two classes of concepts (PKs and cancers); existing evidence suggests that only a subset of PK/cancer pairs participate in a ‘therapeutically relevant’ relation (c.f. Figure 2C), whereby inhibition of a specific protein kinase contributes to the treatment of a certain cancer. The gene discussed is WEE1; the disease is cancer.